This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Eleusis Therapeutics US, Inc.. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: Scott Patrick Worrich: Innovator in Ketamine Treatment
Introduction
Scott Patrick Worrich is an accomplished inventor based in San Antonio, TX (US). He has made significant contributions to the field of medical treatment, particularly in addressing depression and pain through innovative methods.
Latest Patents
Worrich holds a patent for a method of treatment involving ketamine infusion. This patent outlines a process that includes the administration of a first preparation comprising an antiemetic agent, preferably ondansetron, followed by a second preparation of a synergistic combination of ketamine and a benzodiazepine, preferably lorazepam. This method is administered via a continuous intravenous infusion and aims to alleviate symptoms of depression and pain while potentially reducing the need for other medications. He has 1 patent to his name.
Career Highlights
Worrich is associated with Eleusis Therapeutics US, Inc., where he applies his expertise in developing innovative treatment methods. His work focuses on improving patient outcomes through advanced therapeutic approaches.
Collaborations
Worrich collaborates with notable colleagues, including John Bryan Clifton and J Cannon Clifton, who contribute to his research and development efforts.
Conclusion
Scott Patrick Worrich is a pioneering inventor whose work in ketamine treatment represents a significant advancement in medical therapies for depression and pain. His innovative methods have the potential to transform patient care and improve quality of life.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile